CUMYL-CB-MEGACLONE

CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.^[1]

CUMYL-CB-MEGACLONE

Legal status
Legal status	UK: Under Psychoactive Substances Act
Identifiers
IUPAC name 2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclobutylmethyl)-1H-pyrido[4,3-b]indol-1-one
CAS Number	2806439-13-2
PubChem CID	155884737
UNII	U43QX7LH63
Chemical and physical data
Formula	C25H26N2O
Molar mass	370.496 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)(c1ccccc1)N5C=Cc4n(CC2CCC2)c3ccccc3c4C5=O
InChI InChI=1S/C25H26N2O/c1-25(2,19-11-4-3-5-12-19)27-16-15-22-23(24(27)28)20-13-6-7-14-21(20)26(22)17-18-9-8-10-18/h3-7,11-16,18H,8-10,17H2,1-2H Key:XABXFXHKUHKHFO-UHFFFAOYSA-N

See also

• 5F-CUMYL-PEGACLONE
• CUMYL-5F-P7AICA
• CUMYL-CH-MEGACLONE
• CUMYL-BC-HPMEGACLONE-221
• CUMYL-CBMINACA
• CUMYL-THPINACA